What is NeXtGen Biologics worth?
$6.6Mlast known valuation
NeXtGen Biologics last raised $2.2M in its Seed Round (Dec 2018).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for NeXtGen Biologics
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2018 | Seed Round | $2.2M | ▮ | ▮ |
| Aug 2014 | Debt | $500K | ▮ | ▮ |
How NeXtGen Biologics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For NeXtGen Biologics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is NeXtGen Biologics worth?
- NeXtGen Biologics's last known valuation is $6.6M.
- How much has NeXtGen Biologics raised?
- NeXtGen Biologics has raised $6.7M in total funding across 2 recorded rounds.
- When did NeXtGen Biologics last raise?
- NeXtGen Biologics last raised in Dec 2018 (Seed Round), raising $2.2M.